よむ、つかう、まなぶ。
資料３－11－② 森本先生提出資料 (15 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00348.html |
| 出典情報 | 新型コロナウイルス感染症対策アドバイザリーボード（第99回 9／14）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
9.
長崎大学熱帯医学研究所. 新型コロナワクチンの有効性に関する研究第 5 報. Available from
http://www.tm.nagasaki-u.ac.jp/versus/results/20220608.html
10.
Levin EG, Lustig Y, Cohen C, Fluss R, Indenbaum V, Amit S, et al. Waning Immune Humoral Response
to BNT162b2 Covid-19 Vaccine over 6 Months. N Engl J Med. 2021.
11.
Chemaitelly H, Tang P, Hasan MR, AlMukdad S, Yassine HM, Benslimane FM, et al. Waning of
BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar. N Engl J Med. 2021.
12.
Government CIOS' Portal. Japan. Vaccination status of COVID-19 vaccine (general population
(including older adults)). Available from https://cio.go.jp/c19vaccine_dashboard.
13.
Hachmann NP, Miller J, Collier AY, Ventura JD, Yu J, Rowe M, et al. Neutralization Escape by
SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5. N Engl J Med. 2022;387:86-8.
14.
Tuekprakhon A, Nutalai R, Dijokaite-Guraliuc A, Zhou D, Ginn HM, Selvaraj M, et al. Antibody escape
of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. Cell. 2022;185:2422-33.e13.
15.
UK Healtrh Security Agency. COVID-19 vaccine surveillance report Week 31. Available from
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/109632
7/Vaccine_surveillance_report_week_31_2022.pdf.
16.
World
Health
Organization.
Coronavirus.
Available
from
https://www.who.int/health-
topics/coronavirus#tab=tab_3.
17.
Centers for Disease Control and Prevention. Symptoms of Coronavirus 2021. Available from
https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.
18.
Lopez Bernal J, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, et al. Effectiveness of
Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. N Engl J Med. 2021;2021 Aug 12;385:585-594.
13
長崎大学熱帯医学研究所. 新型コロナワクチンの有効性に関する研究第 5 報. Available from
http://www.tm.nagasaki-u.ac.jp/versus/results/20220608.html
10.
Levin EG, Lustig Y, Cohen C, Fluss R, Indenbaum V, Amit S, et al. Waning Immune Humoral Response
to BNT162b2 Covid-19 Vaccine over 6 Months. N Engl J Med. 2021.
11.
Chemaitelly H, Tang P, Hasan MR, AlMukdad S, Yassine HM, Benslimane FM, et al. Waning of
BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar. N Engl J Med. 2021.
12.
Government CIOS' Portal. Japan. Vaccination status of COVID-19 vaccine (general population
(including older adults)). Available from https://cio.go.jp/c19vaccine_dashboard.
13.
Hachmann NP, Miller J, Collier AY, Ventura JD, Yu J, Rowe M, et al. Neutralization Escape by
SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5. N Engl J Med. 2022;387:86-8.
14.
Tuekprakhon A, Nutalai R, Dijokaite-Guraliuc A, Zhou D, Ginn HM, Selvaraj M, et al. Antibody escape
of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. Cell. 2022;185:2422-33.e13.
15.
UK Healtrh Security Agency. COVID-19 vaccine surveillance report Week 31. Available from
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/109632
7/Vaccine_surveillance_report_week_31_2022.pdf.
16.
World
Health
Organization.
Coronavirus.
Available
from
https://www.who.int/health-
topics/coronavirus#tab=tab_3.
17.
Centers for Disease Control and Prevention. Symptoms of Coronavirus 2021. Available from
https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.
18.
Lopez Bernal J, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, et al. Effectiveness of
Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. N Engl J Med. 2021;2021 Aug 12;385:585-594.
13